BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda Y, Shigeno K, Kinoshita N, Nakao K, Yano M, Matsuo H. Sudden hearing loss associated with interferon. Lancet 1994;343:1134-5. [PMID: 7910234 DOI: 10.1016/s0140-6736(94)90237-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Chen H, Lin X, Yi J, Ye W, Wei F, Zhu X, Huang J, Su J. Age-related Activation of Cyclic GMP-AMP synthase-Stimulator of Interferon Genes Signaling in the Auditory System is Associated with Presbycusis in C57BL/6J Male Mice. Neuroscience 2022;481:73-84. [PMID: 34848262 DOI: 10.1016/j.neuroscience.2021.11.031] [Reference Citation Analysis]
2 Jain KK. Drug-Induced Neurootological Disorders. Drug-induced Neurological Disorders 2021. [DOI: 10.1007/978-3-030-73503-6_25] [Reference Citation Analysis]
3 Tanaka M, Hasegawa S, Nakao S, Shimada K, Mukai R, Matsumoto K, Nakamura M. Analysis of drug-induced hearing loss by using a spontaneous reporting system database. PLoS One 2019;14:e0217951. [PMID: 31593579 DOI: 10.1371/journal.pone.0217951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
4 Interferon alfa. Meyler's Side Effects of Drugs 2016. [DOI: 10.1016/b978-0-444-53717-1.00900-8] [Reference Citation Analysis]
5 Interferon beta. Meyler's Side Effects of Drugs 2016. [DOI: 10.1016/b978-0-444-53717-1.00901-x] [Reference Citation Analysis]
6 O’connor KD, Mastaglia FL. Drug-Induced Disorders of the Nervous System. Aminoff's Neurology and General Medicine 2014. [DOI: 10.1016/b978-0-12-407710-2.00032-1] [Reference Citation Analysis]
7 Sposato LA, Fustinoni O. Iatrogenic neurology. Handb Clin Neurol 2014;121:1635-71. [PMID: 24365439 DOI: 10.1016/B978-0-7020-4088-7.00107-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Sharifian MR, Kamandi S, Sima HR, Zaringhalam MA, Bakhshaee M. INF- α and ototoxicity. Biomed Res Int 2013;2013:295327. [PMID: 23984336 DOI: 10.1155/2013/295327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
9 Bae SC, Noh HI, Jun BC, Jeon EJ, Seo JH, Park SY, Kim JK, Lee DH, Oh JH, Park SN, Yeo SW. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Acta Otolaryngol 2013;133:428-33. [PMID: 23356871 DOI: 10.3109/00016489.2012.749520] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
10 Shabana MI, Amer AR, Dabbous AO, Al-sunni AA. Hearing profile in hepatitis C virus patients under dual treatment with interferon and ribavirin. Audiological Medicine 2010;8:142-153. [DOI: 10.3109/1651386x.2010.515708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Arts HA. Sensorineural Hearing Loss in Adults. Cummings Otolaryngology - Head and Neck Surgery 2010. [DOI: 10.1016/b978-0-323-05283-2.00150-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kitada T, Narimatsu T, Yamaguchi S. Sudden hearing loss in a patient with chronic hepatitis C treated with pegylated interferon α2a and ribavirin. Kanzo 2009;50:371-376. [DOI: 10.2957/kanzo.50.371] [Reference Citation Analysis]
13 Mastaglia FL. Drug-Induced Disorders of the Nervous System. Neurology and General Medicine 2008. [DOI: 10.1016/b978-044306707-5.50039-0] [Reference Citation Analysis]
14 Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
15 Sleijfer S, Bannink M, Van Gool AR, Kruit WH, Stoter G. Side effects of interferon-alpha therapy. Pharm World Sci. 2005;27:423-431. [PMID: 16341948 DOI: 10.1007/s11096-005-1319-7] [Cited by in Crossref: 158] [Cited by in F6Publishing: 134] [Article Influence: 9.3] [Reference Citation Analysis]
16 Block F. Hörstörungen. Medikamentös induzierte neurologische und psychiatrische Störungen. [DOI: 10.1007/3-540-28604-7_16] [Reference Citation Analysis]
17 Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004;99:873-7. [PMID: 15128353 DOI: 10.1111/j.1572-0241.2004.30372.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
18 Gervais A, Boyer N, Marcellin P. Tolerability of treatments for viral hepatitis. Drug Saf 2001;24:375-84. [PMID: 11419564 DOI: 10.2165/00002018-200124050-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
19 Chutaputti A. Adverse effects and other safety aspects of the hepatitis C antivirals. J Gastroenterol Hepatol 2000;15 Suppl:E156-63. [PMID: 10921400 DOI: 10.1046/j.1440-1746.2000.02114.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
20 O’brien C, Moonka D. Antiviral Chemotherapy for Viral Hepatitis. Viral Hepatitis 1999. [DOI: 10.1007/978-1-59259-702-4_9] [Reference Citation Analysis]
21 Bailly F, Mattei A, SiAhmed SN, Trepo C. Uncommon side-effects of interferon. J Viral Hepat 1997;4 Suppl 1:89-94. [PMID: 9097285 DOI: 10.1111/j.1365-2893.1997.tb00167.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
22 Revel M. Interferon-beta. Cytokines 1997. [DOI: 10.1016/s1874-5687(97)80034-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-91. [PMID: 8895006 DOI: 10.1016/s0168-8278(96)80113-9] [Cited by in Crossref: 297] [Cited by in F6Publishing: 342] [Article Influence: 11.0] [Reference Citation Analysis]
24 Sotomatsu M, Shimoda M, Ogawa C, Morikawa A. Acute pancreatitis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am J Hematol 1995;48:211-2. [PMID: 7864037 DOI: 10.1002/ajh.2830480321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
25 Vial T, Descotes J. Drugs acting on the immune system. Side Effects of Drugs Annual 1995. [DOI: 10.1016/s0378-6080(05)80162-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
26 Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994;11:318-77. [PMID: 7873092 DOI: 10.2165/00002018-199411050-00004] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 4.7] [Reference Citation Analysis]